GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: example 7i [US8501735]
                                 
                                                         
                            Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: The chemical structure for frevecitinib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a Janus kinase inhibitor with anti-inflammatory potential. The structure matched example 7i in Palau Pharma's patent US8501735 [1].
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
For advanced searching click here to open chemical structure editor
Similar Ligands ![]()  | 
                                                                            |||||||
                                                                                    
  | 
                                                                            
                                                                                
                                                                                
                                                                                
                                                                                
                                                                                    
  | 
                                                                            
                                                                                
                                                                                    ||||||
                                                                                    
  | 
                                                                            
                                                                            |||||||